Discussion on Equity and Commercial Rights for Genetic Resources

November 2009
Citation:
39
ELR 11035
Issue
11
Author
Richard J. Blaustein, Susan Finston, Michael Gollin, David Newman, and David Hegwood

Richard J. Blaustein: Thanks very much for being here. I'm Rich Blaustein. I'm a member of the D.C. Bar Environment and Natural Resources Section. Thank you very much for coming for this conversation and presentation on Equity and Commercial Rights for Genetic Resources. I say great thanks to Jim Rubin for all the support. He's the co-chair of our Environment Section at D.C. Bar and I'll give him the microphone to say hello on behalf of all our different sponsors.

This will be about the fourth event connected with my own interest in the Convention on Biological Diversity (CBD) that the Bar has allowed me to do. In 2004, we had "The CBD in the U.S.A."; Hamdallah Zedan came down [from Montreal] for that and we had panelists, like Mike and Susan, who were on that discussion. I led another in 2008; Ahmed Djoghlaf came down and we had panelists David and Susan and Len Hirsch. Finally, I led one on international policy on ecosystem services, which connects with the Millennium Ecosystem Assessment focus of the CBD.

Speakers: Susan Finston, Executive Director of the Access and Benefit Sharing Alliance Michael Gollin, Venable LLP, and founder of Public Interest Intellectual Property Advisors Dr. David Newman, Chief, Natural Products Branch, National Cancer Institute Dr. Leonard Hirsch, International Programs, Smithsonian Institution David Hegwood, former U.S. Department of Agriculture representative to the United Nations Food and Agriculture Organization
You must be an ELR-The Environmental Law Reporter subscriber to download the full article.

You are not logged in. To access this content:

Discussion on Equity and Commercial Rights for Genetic Resources

SKU: article-23468 Price: $50.00